Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
Ahmet Yozgat(Ufuk University), Murat Kekilli(Gazi University), Mustafa Kaplan(GATA Haydarpaşa Eğitim Hastanesi), Mehmet Göktürk Kaban(Sağlık Bilimleri Üniversitesi), Umut Kara(Türk Anesteziyoloji ve Reanimasyon Derneği), Benan Kasapoğlu(Lokman Hekim Üniversitesi), Yusuf Serdar Sakın(Sağlık Bilimleri Üniversitesi), Müjgan GÜRLER(Bolu Abant İzzet Baysal University), Kadir Serkan Yalçın, Alpaslan Tanoğlu(GATA Haydarpaşa Eğitim Hastanesi), Güray Can(Bolu Abant İzzet Baysal University), Mehmet KIRSOY
Cited by 10
Related Papers
Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis
|Clinics and Research in Hepatology and Gastroenterology|2011|117
Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management
|Blood Purification|2009|112
Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis
|Digestive and Liver Disease|2009|91
Hemostatic Efficacy of Ankaferd Blood Stopper® in a Swine Bleeding Model
|Medical Principles and Practice|2009|86